Clinical and translational results of a phase I study, tocilizumab plus gemcitabine/nab-paclitaxel in patient with gemcitabine/nab-paclitaxel-refractory metastatic pancreatic cancer

被引：0

作者：

Mitsunaga, Shuichi ^{[1
]}

Ikeda, Masafumi ^{[1
]}

Aoki, Kazunori ^{[2
]}

Yamaguchi, Kyoko ^{[3
]}

Sawada, Noriaki ^{[4
]}

Fujii, Etsuko ^{[4
]}

Nishidate, Masanobu ^{[4
]}

Fujitomo, Takashi ^{[4
]}

Mizuno, Hideaki ^{[4
]}

Kayukawa, Yoko ^{[4
]}

Kato, Atsuhiko ^{[5
]}

Makikawa, Mayu ^{[3
]}

Imaoka, Hiroshi ^{[1
]}

Sasaki, Mitsuhito ^{[1
]}

Watanabe, Kazuo ^{[1
]}

Tsunoda, Hiroyuki ^{[4
]}

Terao, Kimio ^{[3
]}

Ochiai, Atsushi ^{[1
]}

机构：

[1] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[2] Natl Canc Ctr, Tokyo, Japan

[3] Chugai Pharmaceut Co Ltd, Tokyo, Japan

[4] Chugai Pharmaceut Co Ltd, Kamakura, Kanagawa, Japan

[5] Chugai Pharmaceut Co Ltd, Shizuoka, Japan

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT565

引用

页数：2

共 50 条

[21] A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus nab-paclitaxel for resectable pancreatic cancer
Tajima, Hidehiro
Makino, Isamu
Gabata, Ryosuke
Okazaki, Mitsuyoshi
Ohbatake, Yoshinao
Shimbashi, Hiroyuki
Nakanuma, Shinich
Saitoh, Hiroto
Shimada, Mari
Yamaguchi, Takahisa
Okamoto, Koichi
Moriyama, Hideki
Kinoshita, Jun
Nakamura, Keishi
Miyashita, Tomoharu
Ninomiya, Itasu
Fushida, Sachio
Ikeda, Hiroko
Ohta, Tetsuo
MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (02) : 1 - 7
[22] Phase I Study of Nab-Paclitaxel plus Gemcitabine as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
Okada, Ken-Ichi
Hirono, Seiko
Kawai, Manabu
Miyazawa, Motoki
Shimizu, Atsushi
Kitahata, Yuji
Ueno, Masaki
Hayami, Shinya
Yamaue, Hiroki
ANTICANCER RESEARCH, 2017, 37 (02) : 853 - 858
[23] Phase I study of nab-paclitaxel and gemcitabine combination in patients with advanced pancreatic cancer
Drengler, R. L.
Smith, L. S.
Wood, T. E.
Borad, M. J.
Ramanathan, R. K.
Laheru, D. A.
Hidalgo, M.
Von Hoff, D. D.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[24] A PHASE I/II TRIAL OF WEEKLY NAB-PACLITAXEL (nab-P) plus GEMCITABINE(G) WITH METASTATIC PANCREATIC CANCER(MPC)
Ikeda, Masafumi
Ueno, Hideki
Ueno, Makoto
Mizuno, Nobumasa
Ioka, Tatsuya
Omuro, Yasushi
Nakajima, Takako
Furuse, Junji
ANNALS OF ONCOLOGY, 2014, 25
[25] Maintenance treatment with gemcitabine after gemcitabine plus Nab-paclitaxel in advanced pancreatic cancer
Kodama, Tomoko
Nakazawa, Junichi
Kawahira, Masahiro
Ymasuji, Akihiro
Iwashita, Yuji
Hori, Takeshi
Kawahira, Machiko
Arima, Shiho
Tubouchi, Hirohito
Ido, Akio
ANNALS OF ONCOLOGY, 2022, 33 : S484 - S484
[26] The retrospective analysis of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer
Ueno, M.
Kobayashi, S.
Ohkawa, S.
Tezuka, S.
Moriya, S.
Morimoto, M.
ANNALS OF ONCOLOGY, 2015, 26 : 67 - 67
[27] Gemcitabine plus nab-paclitaxel use in metastatic pancreatic cancer: A study of 40 patients.
Barrera, Ivan
Filimon, Sabin Dragos
Meng, Jassy
Kavan, Tomas
Rho, Young Soo
Batist, Gerald
Kavan, Petr
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
[28] Reinitiating nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
Borazanci, Erkut
Schroeder, Katy
Jameson, Gayle S.
Ramanathan, Ramesh K.
Von Hoff, Daniel D.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[29] Dose intensity of nab-paclitaxel and gemcitabine chemotherapy in metastatic pancreatic cancer
Lim, Alexander
Kim, Dae Won
Kim, Kunhwa
Kim, Richard D.
Bottiglieri, Salvatore Michael
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
[30] EFFICACY AND SAFETY OF NAB-PACLITAXEL IN COMBINATION WITH GEMCITABINE FOR METASTATIC PANCREATIC CANCER
You, Min Su
Ryu, Ji Kon
Kang, Jinwoo
Choi, Jin Ho
Choi, Young Hoon
Huh, Gunn
Paik, Woo Hyun
Lee, Sang Hyub
Kim, Yong-Tae
GASTROENTEROLOGY, 2018, 154 (06) : S285 - S285

← 1 2 3 4 5 →